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The micro-electrospray ionization source has been optimized for the specific analysis of 
neuropeptides such as neurotensin and methionine enkephalin. The source has the option of 
integrating nanoliter flow-rate desalting and preconcentration techniques into the micro-elec- 
trospray spray needle, eliminating post-column dead volumes. For neurotensin, the most 
sensitive neuropeptide analyzed thus far in this work, the injection of 10 PL of a solution 
containing 320 zeptomoles/pL gave an [M + 3H] c3 ion at m/z 558.4 with S/N of > 81. 
The MS/MS analysis of this peptide for the fragment ion at m/z 578.9 gave a S/N > 2O:l 
for a solution containing 32 attomoles/pL. (J Am Sot Mass Spectrom 1994, 5, 867-869) 
‘e have recently described the development 
W of micro-electrospray (micro-ES) mass spec- trometry for the high sensitivity analysis of 
peptides and proteins [1,2]. This was achieved using a 
modified Vestec electrospray source mounted on a 
Finnigan MAT T!SQ 700 mass spectrometer and opti- 
mizing it for nanoliter flow rates (300-900 nL/min) 
where the eluant was directly sprayed from a fused 
silica capillary needle. Dry ultrapure nitrogen was 
used as a carrier gas. For peptides, a 50 pm (i.d.) 
‘spray’ needle was packed with 1 cm of a reverse 
phase LC packing to act as a desalting/preconcentra- 
tion device. This integrated sample processing/electro- 
spray source allowed small volumes of dilute solutions 
to be analyzed; for example, the direct injection of 10 
PL of a solution containing 100 attomoles/pL of me- 
thionine-enkephalinproduced an [M + HI+ ion at m/z 
574.2 with a signal-to-noise of greater than 5:l obtained 
over a scan range of m/z 550-600. Sequence specific 
ions, e.g. the A, cleavage ion at m/z 397.5, were 
scanned in the MS/MS mode after the injection of 10 
FL of methionine-enkephalin from a 50 attomole/pL 
solution onto the packed needle column. 
We report here work designed to further optimize 
this source and thereby increase sensitivity for the 
specific analysis of neuropeptides. This approach is 
aimed at measuring these neurosubstances in various 
substructures of rat brain at endogenous levels, esti- 
mated to be in the attomoles/pL range in dialysate, 
using a combination of microdialysis and mass spec- 
trometry. In order to achieve the highest sensitivity, it 
was necessary to place the tip of the spray needle as 
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close as possible to the nozzle orifice so as to obtain 
maximum transfer efficiency of the sample. Thus, the 
spray needle, a 22.5 cm length of 50 pm i.d. fused 
silica capillary containing an approximately lo-20 pm 
i.d. orifice and 1 cm of C-18 packing at the spray tip, 
was placed to within approximately 3 mm of the flat 
plate nozzle containing a 400 pm orifice. Another 
problem addressed is the tendency of peptides in very 
low concentrations to bind to the internal surfaces of 
capillaries and injection valves. Ln order to minimize 
this effect for the analysis of dilute solutions of neu- 
rotensin, the entire sample path including the fused 
silica capillary and injector was coated with another 
peptide. This was done by continuously infusing 100 
femtomole/pL of substance P, a peptide known to 
adhere relatively strongly to fused silica, for 30 mm- 
utes at a rate of 0.82 FL/min. This produced a low 
intensity signal at m/z 674.4, the [M + 2H]*’ ion for 
substance I’, which does not interfere with the analysis 
of neurotensin. Also, blank aqueous injections between 
each neurotensin sample analyzed were performed in 
order to verify that there was no carryover from sam- 
ple to sample. 
Overall, this methodology provided an increased 
sensitivity for neurotensin sufficient to give a s/n of 
5:l for the injection of 10 PL of a 320 zeptomole/pL 
solution of the peptide, or a total injection of 3.2 
attomoles. Figure 1 shows the narrow mass range scan 
of the [M + 3H]+3 ion region for this analysis, where 
the peptide was desorbed off the stationary phase 
packing in the micro-ES needle by a 50% 
methanol/water solvent containing 0.25% acetic acid. 
The elution flow rate was 0.82 &/mm, producing a 
peak width of approximately 15 sec. The spectrum 
shown in Figure 1 was produced by averaging scans of 
0.5 set each at the apex of this LC peak (total averaged 
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Figure 1. Direct injection af 10 /LL of a solution of 320 zepto- 
moles/pL of neurotensin onto a C-18 packed micro-electrospray 
needle with subsequent elution by 50% methanol/0.25% acetic 
acid. The spectrum is an average of scans of 0.5 s each taken at 
the apex of an LC peak for about 5 s total width. 
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Figure 2. Continuous infusion of a solution of newotensin 
containing 320 zeptomoles/~L into the micro-electrospray source. 
This spectrum is an average of 16 scans of 0.5 s each, consuming 
a total of 35 zeptomoles of peptide. 
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Figure 3. MS/MS spectrum of the [M + 3H]+” ion of neu- 
rotensin at m/z 558.7 and a doubly-charged product ion at w/z 
578.9 produced from the continuous infusion of a solution con- 
taining 32 attomoles/pL. The spectrum was obtained from an 
average of 16 scans of 0.5 s, each consuming a total of 3.5 
attomoles of peptide. 
time about 5 see). Another benchmark for sensitivity 
that is often used is the amount of sample ‘consumed’ 
in the time period required in producing a particular 
spectrum. Figure 2 shows the mass spectrum from the 
molecular [M + 3H]+” ion region of neurotensin ob- 
tained from the continuous infusion of 320 zepto- 
moles/pL in 50% methanol containing 0.25% acetic 
acid flowing at a rate of 0.82 pL/min. The spray 
needle in the ES source was similar to that described 
above except it did not contain C-18 packing. Approxi- 
mately 35 zeptomoles of neurotensin was consumed 
during the acquisition of this spectrum obtained from 
an average of 16 scans of 0.5 set each. 
MS/MS capabilities are also important in measur- 
ing endogenous peptides because of the highly struc- 
ture specific nature of the analysis. Figure 3 shows the 
narrow m/z range MS/MS scan for the [M + 3H]+3 
molecular ion region of neurotensin (m/z 558.6) with 
collision decomposition to give the doubly-charged Ys 
fragment ion at m/z 578.9, from the continuous infu- 
sion of 32 attomoles/pL at 0.82 pL/min. The spec- 
trum shown in Figure 3 was obtained from the con- 
sumption of 3.5 attomoles of neurotensin using an 
average of 16 scans of 0.5 set each. 
We conclude by noting that these results represent 
the highest sensitivity we have been able to achieve 
with this instrument. It was accomplished using a 
peptide which gives an abundant signal by electro- 
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spray, using water solutions (not physiological salt 
solutions), and scanning relatively narrow mass ranges. 
For dialysate samples from live animals, for example, 
one could expect a lower overall detection limit for 
neurotensin of about 30 attomoles (total injected). The 
ultimate sensitivity achievable in a given experiment is 
dependent on the nature of the peptide of interest, and 
not all peptides will give the same results as neu- 
rotensin. For example, some other peptides we have 
tested, such as methionine-enkephali and substance 
P, gave a SO-fold less intense signal than neurotensin 
for equivalent sample amounts. Nevertheless, these 
data provide a benchmark for the level of sensitivity 
that can be achieved under optimal conditions. 
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